{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:56:56Z","timestamp":1792425416476,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fondazione ART per la Ricerca sui Trapianti ART ONLUS (Milano, Italy)"},{"name":"Fondazione Aiuti per la Ricerca sulle Malattie Rare ARMR ONLUS (Bergamo, Italy)"},{"name":"Telethon grant GGP09075"},{"name":"European Union Seventh Framework Programme FP7-EURenOmics"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.molimm.2016.01.010","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T12:49:23Z","timestamp":1455713363000},"page":"131-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":177,"special_numbering":"C","title":["Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome"],"prefix":"10.1016","volume":"71","author":[{"given":"Paraskevas","family":"Iatropoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Noris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Mele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Piras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Valoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bresin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Curreri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Bettoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Murer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Fremeaux-Bacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Vivarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Emma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Daina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2016.01.010_bib0005","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1681\/ASN.2010080795","article-title":"Allelic variants of complement genes associated with dense deposit disease","volume":"22","author":"Abrera-Abeleda","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2016.01.010_bib0010","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ndt\/gfg605","article-title":"Factor H deficiency and fibrillary glomerulopathy","volume":"19","author":"Bircan","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.molimm.2016.01.010_bib0015","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nrneph.2012.213","article-title":"Pathogenesis of the C3 glomerulopathies and reclassification of MPGN","volume":"8","author":"Bomback","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.molimm.2016.01.010_bib0020","article-title":"High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies","author":"Bu","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2016.01.010_bib0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nrneph.2014.217","article-title":"Histopathology of MPGN and C3 glomerulopathies","volume":"11","author":"Cook","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.molimm.2016.01.010_bib0030","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMc1112273","article-title":"Eculizumab in a patient with dense-deposit disease","volume":"366","author":"Daina","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2016.01.010_bib0035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2016.01.010_bib0040","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/01.ASN.0000115702.28859.A7","article-title":"Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases","volume":"15","author":"Dragon-Durey","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2016.01.010_bib0045","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrneph.2010.85","article-title":"C3 glomerulopathy: a new classification","volume":"6","author":"Fakhouri","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.molimm.2016.01.010_bib0050","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.1195821","article-title":"Structures of C3b in complex with factors B and D give insight into complement convertase formation","volume":"330","author":"Forneris","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.molimm.2016.01.010_bib0055","first-page":"811","article-title":"Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation","volume":"9","author":"Fremeaux-Bacchi","year":"1994","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.molimm.2016.01.010_bib0060","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molimm.2012.05.009","article-title":"Factor H autoantibodies in membranoproliferative glomerulonephritis","volume":"52","author":"Goodship","year":"2012","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2016.01.010_bib0065","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/ki.2013.340","article-title":"Toward a working definition of C3 glomerulopathy by immunofluorescence","volume":"85","author":"Hou","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.molimm.2016.01.010_bib0070","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/ndt\/gfv054","article-title":"Familial C3 glomerulonephritis associated with mutations in the gene for complement factor B","volume":"30","author":"Imamura","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.molimm.2016.01.010_bib0075","doi-asserted-by":"crossref","first-page":"15148","DOI":"10.1074\/jbc.270.25.15148","article-title":"Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46","volume":"270","author":"Iwata","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2016.01.010_bib0080","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.it.2015.04.008","article-title":"Factor H-related proteins determine complement-activating surfaces","volume":"36","author":"Jozsi","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.molimm.2016.01.010_bib0085","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome","volume":"33","author":"Kavanagh","year":"2013","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.molimm.2016.01.010_bib0090","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.ki.5000084","article-title":"Severity of primary MPGN rather than MPGN type, determines renal survival and post-transplantation recurrence risk","volume":"69","author":"Little","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.molimm.2016.01.010_bib0095","doi-asserted-by":"crossref","first-page":"E1445","DOI":"10.1002\/humu.21256","article-title":"Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome","volume":"31","author":"Maga","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molimm.2016.01.010_bib0100","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1093\/ndt\/gft220","article-title":"Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature","volume":"28","author":"Manenti","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.molimm.2016.01.010_bib0105","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1172\/JCI43343","article-title":"Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation","volume":"120","author":"Martinez-Barricarte","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2016.01.010_bib0110","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2215\/CJN.04700513","article-title":"C3 glomerulopathy: clinicopathologic features and predictors of outcome","volume":"9","author":"Medjeral-Thomas","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2016.01.010_bib0115","first-page":"193","article-title":"Glomerular localization of thrombomodulin in human glomerulonephritis","volume":"69","author":"Mizutani","year":"1993","journal-title":"Lab. Invest."},{"key":"10.1016\/j.molimm.2016.01.010_bib0120","first-page":"213","article-title":"Can von Willebrand factor, platelet-endothelial cell adhesion molecule-1 and thrombomodulin be used as alternative markers of endothelial cell injury in human glomerulonephritis?","volume":"49","author":"Niemir","year":"2004","journal-title":"Rocz. Akad. Med. Bialymst"},{"key":"10.1016\/j.molimm.2016.01.010_bib0125","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1074\/jbc.M109.097212","article-title":"Analysis of binding sites on complement factor I that are required for its activity","volume":"285","author":"Nilsson","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2016.01.010_bib0130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/j.ajkd.2015.03.040","article-title":"Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015","volume":"66","author":"Noris","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.molimm.2016.01.010_bib0135","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2016.01.010_bib0140","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","article-title":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2016.01.010_bib0145","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/318201","article-title":"Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome","volume":"68","author":"Perez-Caballero","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molimm.2016.01.010_bib0150","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20070301","article-title":"Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains","volume":"204","author":"Pickering","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2016.01.010_bib0155","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.molimm.2016.01.010_bib0160","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ni.1756","article-title":"Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor","volume":"10","author":"Rooijakkers","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2016.01.010_bib0165","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2014-10-609073","article-title":"Functional mapping of the interactions between complement C3 and regulatory proteins using atypical hemolytic uremic syndrome-associated mutations","author":"Schramm","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2016.01.010_bib0170","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","article-title":"Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies","volume":"82","author":"Servais","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.molimm.2016.01.010_bib0175","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semnephrol.2011.06.005","article-title":"Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification","volume":"31","author":"Sethi","year":"2011","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.molimm.2016.01.010_bib0180","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMra1108178","article-title":"Membranoproliferative glomerulonephritis\u2013a new look at an old entity","volume":"366","author":"Sethi","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2016.01.010_bib0185","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1053\/j.ajkd.2014.10.023","article-title":"C3 glomerulonephritis associated with complement factor B mutation","volume":"65","author":"Sethi","year":"2015","journal-title":"Am. J. Kidney Dis."},{"issue":"Suppl. 3","key":"10.1016\/j.molimm.2016.01.010_bib0190","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2106\/JBJS.H.01623","article-title":"Multicenter collaboration in observational research: improving generalizability and efficiency","volume":"91","author":"Sprague","year":"2009","journal-title":"J. Bone Joint. Surg. Am."},{"key":"10.1016\/j.molimm.2016.01.010_bib0195","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.molimm.2010.02.002","article-title":"Anti-factor B autoantibody in dense deposit disease","volume":"47","author":"Strobel","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2016.01.010_bib0200","doi-asserted-by":"crossref","first-page":"e0136419","DOI":"10.1371\/journal.pone.0136419","article-title":"Development and Validation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Variants for the Clinical Laboratory","volume":"10","author":"Strom","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2016.01.010_bib0205","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1093\/hmg\/ddp289","article-title":"The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity","volume":"18","author":"Tortajada","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molimm.2016.01.010_bib0210","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/01.ATV.0000134298.25489.92","article-title":"Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation","volume":"24","author":"Van de Wouwer","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.molimm.2016.01.010_bib0215","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ni.1755","article-title":"Structure of complement fragment C3b-factor H and implications for host protection by complement regulators","volume":"10","author":"Wu","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2016.01.010_bib0220","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2215\/CJN.07900811","article-title":"Causes of alternative pathway dysregulation in dense deposit disease","volume":"7","author":"Zhang","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589016300116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589016300116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T00:27:51Z","timestamp":1536971271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589016300116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":44,"alternative-id":["S0161589016300116"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2016.01.010","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726158792.793516239","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.726158792.793528918","asserted-by":"object"}]},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2016.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}